Elisa
Lozano Esteban
Profesora Titular de Universidad
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (7)
2023
-
Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity
Cells, Vol. 12, Núm. 8
-
Relevance of the organic anion transporting polypeptide 1B3 (OATP1B3) in the personalized pharmacological treatment of hepatocellular carcinoma
Biochemical Pharmacology, Vol. 214
2020
-
Sensitizing gastric adenocarcinoma to chemotherapy by pharmacological manipulation of drug transporters
Biochemical Pharmacology, Vol. 171
2019
-
Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy
Hepatology, Vol. 70, Núm. 4, pp. 1246-1261
2018
-
Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib
Oncotarget, Vol. 9, Núm. 47, pp. 28474-28485
2016
-
Lack of mitochondrial DNA impairs chemical hypoxia-induced autophagy in liver tumor cells through ROS-AMPK-ULK1 signaling dysregulation independently of HIF-1α
Free Radical Biology and Medicine, Vol. 101, pp. 71-84
2012
-
No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors
Molecular Pharmaceutics, Vol. 9, Núm. 6, pp. 1693-1704